# K121218: Hydrasolve Console Sterile Treatment Kit Reusable Cannula, 4MM Dia, 26 CM Length, 3 Aperture Reusable Cannula, 4MM Dia,

- Pathway: 510(k) (Special)
- Applicant: Andrew Technologies, LLC
- Decided: Dec 13, 2012 after 234 days
- Product code: QPB (System, Suction, Lipoplasty For Removal)
- Device class: 2
- Regulation: 21 CFR 878.5040
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K910696 (1991). 37 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 39 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K092066: Phaser Lipoplasty System (Dur-01), Phaser Disposable Kit (Dis-01), Phaser Waste Collection Kit (Was-01), Phaser Cannulae, Andrew Technologies, LLC (2010) Summary page 5.

## Most influential descendants
- K130152: Hydrasolve Lipoplasty System (2013), 0 descendants of its own

## Indications for use
The HydraSolve Lipoplasty System is intended to be used for liquefaction and aspiration of localized subcutaneous fatty deposits for the purpose of aesthetic body contouring. The HydraSolve Lipoplasty System is indicated for use in aesthetic body contouring.

Source page: https://510kreport.com/device/K121218
Methodology: https://510kreport.com/methodology
